Skip to main content
. 2021 May 16;2(6):100311. doi: 10.1016/j.xcrm.2021.100311
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies

Anti-SARS-CoV-2 NP mAb #7 This study N/A
Anti-SARS-CoV-2 NP mAb #9 This study N/A
Anti-SARS-CoV-2 NP mAb #98 This study N/A
Anti-His-tag mAb MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. Cat# D291-3;RRID: AB_10597733
Anti-DDDDK-tag (Flag) mAb MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. Cat#M185-3L; RRID: AB_11123930
SARS-CoV-2 Nucleocapsid Protein Monoclonal Antibody (7E1B) Bioss Antibodies Inc. Cat#bsm-41414M; RRID: AB_2848129
SARS coronavirus monoclonal antibody BiosPacific, Inc. Cat#A03070041P
SARS coronavirus monoclonal antibody BiosPacific, Inc. Cat#A03080041P
Anti-Mouse IgG, HRP-Linked F(ab’)2 Fragment Sheep Cytiva Cat#NA9310-1ML; RRID: AB_772193
Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 568 Thermo Fisher Scientific Cat#A-11031; RRID: AB_144696

Bacterial and virus strains

SARS-CoV-2 isolate (2019-nCoV/JPN/TY/WK-521/2020) National Institute of Infectious Diseases, Japan N/A
SARS-CoV-2 isolate (2019-nCoV/JPN/QHN001/2021) National Institute of Infectious Diseases, Japan N/A
SARS-CoV-2 isolate (2019-nCoV/JPN/TY8-612/2021) National Institute of Infectious Diseases, Japan N/A
SARS-CoV-2 isolate (2019-nCoV/JPN/TY7-501/2021) National Institute of Infectious Diseases, Japan N/A
Human coronavirus OC43 American Type Culture Collection (ATCC) Cat#VR-1558
Human coronavirus 229E American Type Culture Collection (ATCC) Cat#VR-740
Human rhino virus 14 (HRV14) American Type Culture Collection (ATCC) Cat#VR-284
Human rhino virus 14 (HRV16) American Type Culture Collection (ATCC) Cat#VR-283
Respiratory syncytial virus (RSV) American Type Culture Collection (ATCC) Cat#VR-26
Influenza A virus (IFAV) H1N1 pdm09 isolate (A/Yokohama/72/2020) Yokohama City Institute of Public Health, Kanagawa, Japan N/A
Influenza A virus (IFAV) H3N2 isolate (A/Yokohama/68/2020) Yokohama City Institute of Public Health, Kanagawa, Japan N/A
Influenza B virus (IFBV) Victoria lineage isolate (B/Yokohama/33/2020) Yokohama City Institute of Public Health, Kanagawa, Japan N/A
Influenza B virus (IFBV) Yamagata lineage isolate (B/Yokohama/35/2019) Yokohama City Institute of Public Health, Kanagawa, Japan N/A

Chemicals, peptides, and recombinant proteins

PrimeSTAR Mutagenesis Basal kit Takara Bio Inc. Cat#R046A
WEPRO7240H Expression Kit CellFree Sciences Co.,Ltd. Cat#CFS-TRI-7240H
WEPRO7240G Expression Kit CellFree Sciences Co.,Ltd. Cat#CFS-TRI-7240G
Hi-QRAS Gel N Kanto Chemical Co., Inc. Cat#49902-58
Rapid CBB KANTO 3S Kanto Chemical Co., Inc. Cat#36533-79
His-tagged N-terminal deleted mutant of NP (ΔN-NP; 121-419) This study N/A
Ni-Sepharose Fast Flow beads Cytiva Cat#17531801
PreScission Protease Cytiva Cat#27084301
ABTS Microwell Peroxidase Substrate (2-Component System) Kirkegaard & Perry Laboratories Cat#5120-0032
TMB 1-Component Microwell Peroxidase Substrate, SureBlue Kirkegaard & Perry Laboratories Cat#5120-0075
SuperSignal West Femto Maximum Sensitivity Substrate Thermo Fisher Scientific Cat#34095
Dulbecco’s modified Eagle’s medium (high glucose) FUJIFILM Wako Pure Chemical Corporation Cat#044-29765
CD hybridoma medium AGT medium Thermo Fisher Scientific Cat#12372025
HYGM-7 Express (Ready - to - use), Liquid, without Phenol Red, protein free Kanto Chemical Co., Inc. Cat#49432-50

Critical commercial assays

Standard Q COVID-19 Ag SD. Biosensor Cat#Q-NCOV-01G
Espline SARS-CoV-2 Fujirebio Cat#260319
Panbio COVID-19 Ag Rapid Test Abbott Cat#4571226475003
SARS-CoV-2 Rapid Antigen Test Roche Cat#508487

Deposited data

Partial structure of SARS-CoV-2 NP-1 Zinzula et al.24 PDB: 6YUN
Full-length structural model of MERS-NP Yamaoka et al.21 N/A
Partial structure of SARS-CoV-2 NP-2 Kang et al.23 PDB: 6M3M
Full-length structural model of SARS-CoV-2 NP This study https://doi.org/10.17632/7b67yg29d6.1
Multiple sequence alignment of SARS-CoV-2 NP This study https://doi.org/10.17632/7b67yg29d6.1

Experimental models: cell lines

HCT-8 American Type Culture Collection (ATCC) CCL-244
MRC-5 RIKEN BioResource Research Center RCB0211
VeroE6/TMPRSS2 Japanese Collection of Research Bioresources Cell Bank (JCRB) JCRB1819

Oligonucleotides

Reverse primer for the quantification of SARS-CoV-2: 5′- TGGCAGCTGT
GTAGGTCAAC −3′
Shirato et al.42 N/A
Probe for the quantification of SARS-CoV-2: FAM-ATGTCGCGCATTGGCATGGA-BHQ Shirato et al.42 N/A
Forward primer for the quantification of HCoV-229E: 5′- TTCCGACGT
GCTCGAACTTT −3′
Vijgen et al.43 N/A
Reverse primer for the quantification of HCoV-229E: 5′- CCAACACGGTTG
TGACAGTGA −3′
Vijgen et al.43 N/A
Probe for the quantification of HCoV-229E: FAM 5′- TCCTGAGGTCAATGCA −3′ TAMRA Vijgen et al.43 N/A
Forward primer for the quantification of HCoV-OC43: 5′- ATGTTAGGCCGATA
ATTGAGGACTAT −3′
Vijgen et al.43 N/A
Reverse primer for the quantification of HCoV-OC43: 5′- AATGTAAAGA
TGGCCGCGTATT −3′
Vijgen et al.43 N/A
Probe for the quantification of HCoV-OC43: FAM 5′- CATACTCTGACGGTCACAAT −3′ TAMRA Vijgen et al.43 N/A
Forward primer for the quantification of SARS-CoV-2: 5′- AAATTTTGGGG
ACCAGGAAC −3′
Shirato et al.42 N/A

Software and algorithms

ForteBio data analysis software Fortebio https://www.sartorius.com/en/products/protein-analysis/octet-systems-software
MODELLER9.15 Webb et al.44 https://salilab.org/modeller/9.15/release.html
Swiss PDB viewer 4.1 Guex et al.45 https://spdbv.vital-it.ch/
UCSF Chimera software 1.13.1 Pettersen et al.46 https://www.cgl.ucsf.edu/chimera/
MAFFT version 7 Kato et al.47 https://mafft.cbrc.jp/alignment/server/
MEGAX (MUSCLE) Edgar et al.48, Kumar et al.49 https://www.megasoftware.net/
Graphpad Prism 8.43 Graphpad Software https://www.graphpad.com/

Other

Immunochromatographic assay with silver amplification technology This study (FUJIFILM Corporation) Cat#16696722